Diana Whitaker‐Menezes
机构:Thomas Jefferson University, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center · ORCID:0009-0008-6051-1431
发表论文 142 篇 · 总被引 11639 次 · h-index 54
代表论文
- TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c‐MYC and NFkB activation in breast cancer (2023 · International Journal of Cancer · 被引 26)
- MiR-200c reprograms fibroblasts to recapitulate the phenotype of CAFs in breast cancer progression (2024 · Cell Stress · 被引 5)
- Extracellular Matrix–MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC (2025 · Clinical Cancer Research · 被引 4)
- TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis (2025 · Molecular Oncology · 被引 4)
- Supplementary Figure S8 from Extracellular Matrix–MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC (2025)
- Supplementary Figure S2 from Extracellular Matrix–MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC (2025)